《大行報告》匯豐研究下調ASMPT(00522.HK)目標價至65元 評級「持有」
匯豐研究發表研報指,ASMPT(00522.HK)第二季收入僅按年增長0.5%,較該行及市場預期各低8%及5%,不過由於SMT業務利潤率表現有所改善,第二季利潤率增長至41.7%,帶動期內盈利表現。
該行指,由於高基數效應,ASMPT第二季新增訂單總額為5.93億美元,按年下跌36.5%,當中先進包裝 及汽車相關業務繼續呈現強勁勢頭,佔總訂單量的46%。該行指出,第三季指引低於預期,反映公司估計新增訂單將下降,實際情況取決於宏觀環境是否會進一步惡化。
匯豐研究將2022至2023財年每股盈利預測下調2%及7%,以反映指引較弱,維持「持有」評級,目標價從85元下調至65元,認為ASMPT未來需求疲軟及缺乏短期催化劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.